Investing With IBD cover image

Ep 162: David Saito-Chung: What Can The Fed Hikes Of 1994 Teach Us?

Investing With IBD

00:00

Alcramies Stocks: A Long Journey to Wilderness

The stock had traded as high as 80 way back in 2015 and so it has been a long journey through to wilderness if you will. The company is expected to actually post a net loss of 10 cents a share, which makes me more curious about what's going on with the company. On the technical side we have a up-down volume ratio of 1.4 that means that volume on the up days is 40 percent higher than overall volume on the down days in this stock.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app